As of 2026-03-16, the Intrinsic Value of Cullinan Oncology Inc (CGEM) is -18.35 USD. This CGEM valuation is based on the model Peter Lynch Fair Value. With the current market price of 13.49 USD, the upside of Cullinan Oncology Inc is -236.02%.
Based on its market price of 13.49 USD and our intrinsic valuation, Cullinan Oncology Inc (CGEM) is overvalued by 236.02%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -18.35 - -18.35 | -18.35 | -236.02% |
| P/E | (84.04) - (97.84) | (89.18) | -761.1% |
| DDM - Stable | (20.83) - (48.73) | (34.78) | -357.8% |
| DDM - Multi | (14.18) - (26.15) | (18.42) | -236.6% |
| Market Cap (mil) | 796.99 |
| Beta | 0.70 |
| Outstanding shares (mil) | 59.08 |
| Enterprise Value (mil) | 693.65 |
| Market risk premium | 4.60% |
| Cost of Equity | 13.55% |
| Cost of Debt | 5.00% |
| WACC | 9.23% |